研報掘金丨長江證券:首予藍曉科技“買入”評級,公司業務實現大幅拓展
長江證券研報指出,藍曉科技(300487.SZ)為吸附分離材料行業龍頭,金屬資源、生命科學、水處理與超純化、食品加工、節能環保、化工與催化等領域取得快速成長,預計2024-2026年歸屬淨利潤分別為8.4/10.8/13.2億元,首次覆蓋,給予“買入”評級。近兩年大量項目落地,公司業務實現大幅拓展。同時,公司積極推動在鎳、鈷、釩、鎢等金屬領域的突破量產及規模化銷售。在食品加工領域,無糖領域新添需求,節能環保領域,工業廢水處理市場保持較快增長,公司積極導入。公司結合材料製造、應用工藝、系統裝置三方面技術優勢,率先提出成套吸附分離技術整體解決方案的業務模式,可滿足不同客户的柔性需求;同時公司積極出海,擁抱廣闊的增量市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.